These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 25093288)
1. Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary. Vierkoetter KR; Ayabe AR; VanDrunen M; Ahn HJ; Shimizu DM; Terada KY Gynecol Oncol; 2014 Oct; 135(1):81-4. PubMed ID: 25093288 [TBL] [Abstract][Full Text] [Related]
2. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset. Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223 [TBL] [Abstract][Full Text] [Related]
3. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970 [TBL] [Abstract][Full Text] [Related]
4. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas. Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366 [TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706 [TBL] [Abstract][Full Text] [Related]
6. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy. Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451 [TBL] [Abstract][Full Text] [Related]
7. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers. Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547 [TBL] [Abstract][Full Text] [Related]
9. High homogeneity of MMR deficiency in ovarian cancer. Fraune C; Rosebrock J; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Höflmayer D; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Clauditz TS; Wilczak W; Sauter G; Steurer S; Burandt E Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer. Hodan R; Kingham K; Cotter K; Folkins AK; Kurian AW; Ford JM; Longacre T Cancer Med; 2021 Feb; 10(3):1012-1017. PubMed ID: 33369189 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542 [TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768 [TBL] [Abstract][Full Text] [Related]
14. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis. Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091 [TBL] [Abstract][Full Text] [Related]
15. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634 [TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors. Ketabi Z; Bartuma K; Bernstein I; Malander S; Grönberg H; Björck E; Holck S; Nilbert M Gynecol Oncol; 2011 Jun; 121(3):462-5. PubMed ID: 21388660 [TBL] [Abstract][Full Text] [Related]
17. Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas. Djordjevic B; Barkoh BA; Luthra R; Broaddus RR Mod Pathol; 2013 Oct; 26(10):1401-12. PubMed ID: 23599155 [TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer]. Jin W; Wang LQ; Liu Y; Liu AJ Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020 [No Abstract] [Full Text] [Related]
19. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening. Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272 [TBL] [Abstract][Full Text] [Related]
20. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]